Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1990 Jun;34(6):1088-93.
doi: 10.1128/AAC.34.6.1088.

Mechanism of action of lomefloxacin

Affiliations
Comparative Study

Mechanism of action of lomefloxacin

L J Piddock et al. Antimicrob Agents Chemother. 1990 Jun.

Abstract

The inhibition of supercoiling activity of reconstituted Escherichia coli DNA gyrase by lomefloxacin, ciprofloxacin, and norfloxacin was determined. The concentrations of quinolones needed to inhibit DNA synthesis in Escherichia coli, Enterobacter cloacae, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus were also measured. The kinetics of uptake of [14C]lomefloxacin and unlabeled lomefloxacin into whole cells of E. coli KL-16 and S. aureus NCTC 8532 and the induction of RecA in E. coli GC2241 were assayed. All strains had wild-type susceptibilities to quinolones. The concentration of quinolones needed to inhibit DNA synthesis by 50% correlated with the MIC for members of the family Enterobacteriaceae and P. aeruginosa. The concentration of quinolones needed to inhibit DNA synthesis by 50% for late-logarithmic-phase S. aureus also correlated with the MIC, unlike the data from early-logarithmic-phase cultures. E. coli and S. aureus showed a similar pattern of uptake kinetics of [14C]lomefloxacin and unlabeled lomefloxacin, indicating that the difference in the susceptibilities of the two species is probably due to different target site affinities. Essentially, lomefloxacin was less active than ciprofloxacin and ofloxacin and had activity similar to those of norfloxacin and enoxacin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Mol Biol. 1973 Feb 25;74(2):205-21 - PubMed
    1. Mol Gen Genet. 1982;185(3):430-9 - PubMed
    1. J Biol Chem. 1984 Jul 25;259(14):9199-201 - PubMed
    1. Antimicrob Agents Chemother. 1986 Jan;29(1):1-6 - PubMed
    1. J Antimicrob Chemother. 1990 Mar;25(3):319-33 - PubMed

Publication types

MeSH terms

LinkOut - more resources